Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters

Between September 1993 and December 1993, during extensive hospital construction and indoor renovation, a nosocomial outbreak of invasive pulmonary aspergillosis occurred in acute leukemia patients treated in a regular ward that has only natural ventilation. The observed infection rate was 50%. Chemoprophylaxis with intravenous continuous low‐dose amphotericin B was then instituted as a preventive measure. During the next 18 months invasive pulmonary aspergillosis developed in 43% of acute leukemia patients. After that period a new hematology ward was opened with an air filtration system through high‐efficiency particulate air filtration (HEPA) filters, and a bone marrow transplantation program was started on the hematology service. During the following three years, none of the acute leukemia or bone marrow transplantation patients who were hospitalized exclusively in the hematology ward developed invasive pulmonary aspergillosis, although 29% of acute leukemia patients who were housed in a regular ward, because of shortage of space in the new facility, still contracted invasive pulmonary aspergillosis. Overall, 31 patients were diagnosed with invasive pulmonary aspergillosis during almost five years: 74% of patients recovered from invasive pulmonary aspergillosis, and 42% are long‐term survivors; 26% of patients died of resistant leukemia with aspergillosis, but no one died of invasive pulmonary aspergillosis alone. In conclusion, during an on‐going construction period, an extremely high incidence rate of invasive pulmonary aspergillosis in acute leukemia patients undergoing intensive chemotherapy was observed. Institution of low‐dose intravenous amphotericin B prophylaxis marginally reduced the incidence rate of invasive pulmonary aspergillosis. Keeping patients in a special ward with air filtration through a HEPA system eliminated invasive pulmonary aspergillosis completely. Among patients who developed invasive pulmonary aspergillosis, early diagnosis and treatment are probably the explanation for the favorable outcome. Am. J. Hematol. 66:257–262, 2001. © 2001 Wiley‐Liss, Inc.

[1]  S. Hinrichs,et al.  Airborne Fungal Spore Monitoring in a Protective Environment During Hospital Construction, and Correlation with an Outbreak of Invasive Aspergillosis , 1994, Infection Control & Hospital Epidemiology.

[2]  M. Richardson,et al.  Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. , 1996, Thorax.

[3]  Catherine Dixon,et al.  Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit , 1996 .

[4]  J. Miller,et al.  Primary cutaneous aspergillosis associated with Hickman intravenous catheters. , 1987, The New England journal of medicine.

[5]  K. Cummings,et al.  Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. , 1989 .

[6]  M. Schousboe,et al.  Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. , 1991, The American journal of medicine.

[7]  G. Rosner,et al.  Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. , 1992, The Journal of infectious diseases.

[8]  L. Fouillard,et al.  Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis. , 1996, Bone marrow transplantation.

[9]  M. Kletzel,et al.  Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. , 1997, Medical and pediatric oncology.

[10]  J. Jones,et al.  The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. , 1986, American journal of clinical pathology.

[11]  T. Patterson,et al.  Aspergillus antigen detection in the diagnosis of invasive aspergillosis. , 1995, The Journal of infectious diseases.

[12]  G. Talbot,et al.  Invasive aspergillus rhinosinusitis in patients with acute leukemia. , 1991, Reviews of infectious diseases.

[13]  J. Nemunaitis,et al.  Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. , 1993, Blood.

[14]  A. Groll,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.

[15]  S. Forman,et al.  The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. , 1992, Respiratory medicine.

[16]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[17]  B. Kramer,et al.  Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. , 1987, The American journal of medicine.

[18]  A. Bernard,et al.  Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Gottlieb,et al.  Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. , 1991, The American journal of medicine.

[20]  J. Armitage,et al.  Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants , 1993, Infection Control & Hospital Epidemiology.